| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/22/1998 | WO1998002165A1 Appetite suppression |
| 01/22/1998 | WO1998002164A1 Treatment of equine protozoal myeloencephalitis |
| 01/22/1998 | WO1998002163A1 Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors |
| 01/22/1998 | WO1998002162A1 Heterocyclic compounds with thrombolytic activity and their use for treating thrombosis |
| 01/22/1998 | WO1998002161A1 Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors |
| 01/22/1998 | WO1998002160A1 Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
| 01/22/1998 | WO1998002159A1 Novel treatment of leptine resistance |
| 01/22/1998 | WO1998002158A1 Alteration of circadian rhythmicity with a tachykinin antagonist |
| 01/22/1998 | WO1998002157A1 Pharmaceutical formulations for topical application containing as an active ingredient a carbazolyl-(4)-oxy-propanol amine derivate |
| 01/22/1998 | WO1998002156A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for lowering intraocular pressure |
| 01/22/1998 | WO1998002155A1 2-phenyl-3-azoylbenzothiophene for lowering intraocular pressure |
| 01/22/1998 | WO1998002154A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome |
| 01/22/1998 | WO1998002153A1 Ceramide promotors of haematopoiesis |
| 01/22/1998 | WO1998002152A1 Pharmaceutical compositions comprising s-(-)-n-propargyl-1-amino indan |
| 01/22/1998 | WO1998002151A2 Chemokine receptor antagonists and methods of use therefor |
| 01/22/1998 | WO1998002149A2 Use of idebenone and analogues against beta amyloid induced cytotoxicity |
| 01/22/1998 | WO1998002148A2 Pharmaceutical composition |
| 01/22/1998 | WO1998002147A2 Transdermal therapeutic systems |
| 01/22/1998 | WO1998002145A2 β-LACTAM GRANULES FREE OF ORGANIC SOLVENTS |
| 01/22/1998 | WO1998002144A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | WO1998002042A1 Methods for eliminating parasites and in particular ectoparasites of vertebrates, particularly of mammals and compositions for implementing these methods |
| 01/22/1998 | WO1998002041A1 Therapeutic composition from sugar cane and therapeutic uses thereof |
| 01/22/1998 | WO1997035591A3 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 01/22/1998 | WO1996020698A3 Surface-modified nanoparticles and method of making and using same |
| 01/22/1998 | DE19734693A1 Use of cariporide to treat cardiac and non-cardiac disease |
| 01/22/1998 | DE19730990A1 New (amidino-phenyl)-(benzo:dioxolo-methyl)oxo-pyrrolo:pyrrole compounds |
| 01/22/1998 | DE19629032A1 Ephedringranulat mit hohem Wirkstoffgehalt Ephedrine granules with high content of active substance |
| 01/22/1998 | DE19628776A1 Oral applizierbare Granulate von Hexahydropyrazinderivaten Administered Orally granules of Hexahydropyrazinderivaten |
| 01/22/1998 | CA2261591A1 Adenosine deaminase inhibitors |
| 01/22/1998 | CA2261072A1 Substituted n-arylmethylamino derivatives of cyclobutene-3,4-diones |
| 01/22/1998 | CA2261023A1 Novel catalytic rna molecules |
| 01/22/1998 | CA2260965A1 Heterocyclic compounds with thrombolytic activity and their use for treating thrombosis |
| 01/22/1998 | CA2260892A1 Appetite suppression |
| 01/22/1998 | CA2260738A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | CA2260284A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | CA2260269A1 Alteration of circadian rhythmicity with a tachykinin antagonist |
| 01/22/1998 | CA2260258A1 Wound healing accelerators |
| 01/22/1998 | CA2260216A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
| 01/22/1998 | CA2260214A1 Methods of enhancing lean tissue mass and bone mineral content and compositions therefor |
| 01/22/1998 | CA2260061A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | CA2260058A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | CA2260044A1 Novel treatment of leptine resistance |
| 01/22/1998 | CA2260034A1 Cationic amphiphile/dna complexes |
| 01/22/1998 | CA2260029A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 01/22/1998 | CA2259927A1 Chemokine receptor antagonists and methods of use therefor |
| 01/22/1998 | CA2259418A1 Pharmaceutical composition containing acid addition salt of basic drug |
| 01/22/1998 | CA2259371A1 Therapeutic multispecific compounds comprised of anti-fc.alpha. receptor antibodies |
| 01/22/1998 | CA2258685A1 Silanol enzyme inhibitors |
| 01/22/1998 | CA2257984A1 Bromotiacumicin compounds |
| 01/22/1998 | CA2257860A1 Inclusion complex containing indole selective serotonin agonist |
| 01/22/1998 | CA2255073A1 Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
| 01/22/1998 | CA2252519A1 Use of idebenone and analogues against beta amyloid induced cytotoxicity |
| 01/22/1998 | CA2232297A1 Therapeutic composition from sugar cane and therapeutic uses thereof |
| 01/21/1998 | EP0819703A2 Ether derivatives of polymeric glucans, their preparation as well as their use |
| 01/21/1998 | EP0819698A2 Fluoroalkyl uronic acid glycosides and the corresponding 6(3)-lactones, preparation and use |
| 01/21/1998 | EP0819692A1 Kojic acid derivative as depigmentation agent |
| 01/21/1998 | EP0819687A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/21/1998 | EP0819686A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/21/1998 | EP0819681A2 N-(4-Aryl-thiazol-2-yl)-sulfonamides and their use |
| 01/21/1998 | EP0819438A2 Buprenorphine percutaneous absorption preparation |
| 01/21/1998 | EP0819436A2 Pharmaceutical and dietary composition containing sodium-, potassium-, magnesium- and calcium-ions and enzyme activators |
| 01/21/1998 | EP0819434A1 Use of PHMB for the treatment of tumors |
| 01/21/1998 | EP0819433A2 Compositions for increasing the efficacy of cancer drugs with tea catechin and/or theaflavin |
| 01/21/1998 | EP0819432A1 Antitumor agents comprising as the principal agent compounds containing silicon and nitrogen |
| 01/21/1998 | EP0819431A1 Agent for prophylaxis and treatment of disturbance of visual function |
| 01/21/1998 | EP0819430A1 Inhibitor of tumor metastasis or recurrence |
| 01/21/1998 | EP0819380A1 Bacteriocidal, antibacterial and bacteriostatic composition |
| 01/21/1998 | EP0819177A1 Expression library immunization |
| 01/21/1998 | EP0819169A1 Methods for screening compounds for estrogenic activity |
| 01/21/1998 | EP0819167A2 Dna encoding galanin galr2 receptors and uses thereof |
| 01/21/1998 | EP0819136A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same |
| 01/21/1998 | EP0819135A1 Sugar-modified cytostatics |
| 01/21/1998 | EP0819130A1 Ascomycins |
| 01/21/1998 | EP0819129A1 Pyrazole derivatives and processes for the preparation thereof |
| 01/21/1998 | EP0819128A1 Tricyclic compounds useful in the treatment of cell proliferative disorders |
| 01/21/1998 | EP0819127A1 IMIDAZO [1,2-a]PYRIDINE DERIVATIVES |
| 01/21/1998 | EP0819126A1 Biphenylamide derivatives as 5ht 1d? antagonists |
| 01/21/1998 | EP0819125A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/21/1998 | EP0819124A1 Azole compounds with antimycotic activity for human and veterinary use |
| 01/21/1998 | EP0819123A1 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity |
| 01/21/1998 | EP0819122A1 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
| 01/21/1998 | EP0819121A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/21/1998 | EP0819120A1 Tricyclic compounds useful for inhibition of farnesyl protein transferase |
| 01/21/1998 | EP0819113A1 Benzamides for neurodegenerative disorder treatment |
| 01/21/1998 | EP0819107A1 9-substituted porphycenes |
| 01/21/1998 | EP0819004A1 Pharmaceutical composition containing proton pump inhibitors |
| 01/21/1998 | EP0819003A1 A method for the treatment of macular degeneration |
| 01/21/1998 | EP0819002A1 USE OF IMIDAZOL 1,2-a]PYRIDINE-3-ACETAMIDE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF NEUROPSYCHIATRIC SYNDROMES ASSOCIATED WITH DISFUNCTION OF THE NEURAL CIRCUITS OF THE BASAL GANGLIA |
| 01/21/1998 | EP0819001A1 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders |
| 01/21/1998 | EP0819000A1 Nodulisporic acid derivatives |
| 01/21/1998 | EP0818999A1 Pharmaceutical agents for the treatment of alzheimer's disease |
| 01/21/1998 | EP0818998A1 Composition and process for prevention and treatment of cutaneous delayed hypersensitivity reactions |
| 01/21/1998 | EP0818997A1 Compositions including amiodarone and betaxolol |
| 01/21/1998 | EP0818994A1 Method of making a pressure sensitive skin adhesive sheet material |
| 01/21/1998 | EP0818992A1 Procedure for encapsulating nsaids |
| 01/21/1998 | EP0818990A1 Homogeneous mixtures of low temperature-melting drugs and additives for controlled release |
| 01/21/1998 | EP0818987A1 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions |
| 01/21/1998 | EP0818957A2 Calcium supplements and calcium containing beverages comprising vitamin d |
| 01/21/1998 | EP0818956A1 Cereal food product high in soluble fiber |
| 01/21/1998 | EP0729353A4 Preparation of biodegradable microparticles containing a biologically active agent |